Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:46 PM
Ignite Modification Date:
2025-12-26 @ 10:46 PM
NCT ID:
NCT05488912
Eligibility Criteria:
Inclusion Criteria:
* Two groups of participants will be recruited:
1. Healthy BMI (20-25 kg/m2, n=30), and
2. Overweight/Obese BMI (\>28 kg/m2, n=30)
* Other inclusion criteria are as follows:
* Adult men and women (18-55 years of age) residing in a SNAP-eligible households;
* Self-identifying as Hispanic or Latino, and with origin or cultural background from a Spanish-speaking Latin American country;
* Willingness and ability to provide a signed informed consent; and
* Willingness to complete study visits and participate in all aspects of the study.
Exclusion Criteria:
* Adults reporting any of the following conditions will be excluded from the study:
* Diagnosed type 2 diabetes, chronic kidney or liver disease, cancer, chronic gastrointestinal conditions, cognitive impairment or incapacitating mental health problems, lack of mobility and physical independence, self-reported weight loss \>5 kg within past 6 months, history of communicable or chronic diseases, medication use or surgery that would preclude safe and active study participation, bariatric surgery, antibiotic use within past 3 months, ongoing participation in other clinical trials, use of anti-obesity medications within the past year, inability to communicate in oral and written form in English and/or Spanish, and habitual consumption of more than two alcoholic drinks per day or of illegal drugs.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
55 Years
Study:
NCT05488912
Study Brief:
Protocol Section:
NCT05488912